Esophageal Eosinophilic Infiltration Responds to Proton Pump Inhibition in Most Adults

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 2, 2011, Pages 110-117

  Molina Infante, Javier ^a   Ferrando Lamana, Lucia ^a   Ripoll, Cristina ^b   Hernandez Alonso, Moises ^a   Mateos, Jose M ^a   Fernandez Bermejo, Miguel ^a   Dueñas, Carmen ^a   Fernandez Gonzalez, Nuria ^a   Quintana, Eva M ^a   Gonzalez Nuñez, Maria Angeles ^a  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Allergy; Eosinophil; Eosinophilic Esophagitis; Esophageal pH Monitoring; Gastroesophageal Reflux Disease; Proton Pump Inhibitors; Sensitivity; Specificity

Indexed keywords

RABEPRAZOLE;

ABDOMINAL PAIN; ADULT; AGED; ALLERGY; ANEMIA; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIARRHEA; DYSPEPSIA; DYSPHAGIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGEAL EOSINOPHILIC INFILTRATION; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HIATUS HERNIA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; SENSITIVITY AND SPECIFICITY; THORAX PAIN; TREATMENT DURATION; VOMITING; WEIGHT REDUCTION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; CELL COUNT; DEGLUTITION DISORDERS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILS; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; FOOD; GASTROESOPHAGEAL REFLUX; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; MUCOUS MEMBRANE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 78751684742     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.09.019     Document Type: Article

References (40)

1. Furuta G.T., Liacouras C.A., Collins M.H., et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007, 133:1342-1363.
2. Lucendo A.J., Pascual-Turrión J.M., Navarro M., et al. Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy 2007, 39:765-771.
3. Müller S., Pühl S., Vieth M., et al. Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy 2007, 39:339-344.
4. Dellon E.S., Aderoju A., Woosley J.T., et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007, 102:1-14.
5. Kapel R.C., Miller J.K., Torres C., et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008, 134:1316-1321.
6. Attwood S.E., Lewis C.J., Bronder C.S., et al. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut 2003, 52:181-185.
7. Arora A.S., Perrault J., Smyrk T.C. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 2003, 78:830-835.
8. Morrow J.B., Vargo J.J., Goldblum J.R., et al. The ringed esophagus: histological features of GERD. Am J Gastroenterol 2001, 96:984-989.
9. Desai T.K., Stecevic V., Chang C.H., et al. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc 2005, 61:795-801.
10. Ngo P., Furuta G.T., Antonioli D.A., et al. Eosinophils in the esophagus: peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006, 101:1666-1670.
11. Rodrigo S., Abboud G., Oh D., et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol 2008, 103:435-442.
12. Sayej W.N., Patel R.A., Baker R.D., et al. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009, 49:1-7.
13. Peterson K.A., Thomas K.L., Hilden K., et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 2010, 55:1313-1319.
14. Assáad A. Eosinophilic esophagitis: association with allergic disorders. Gastrointest Endosc Clin N Am 2008, 18:119-132.
15. Fox V.L. Eosinophilic esophagitis: endoscopic findings. Gastrointest Endosc Clin N Am 2008, 18:45-57.
16. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006, 101:1900-1920.
17. Odze R.D. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol 2009, 104:485-490.
18. Long J.D., Orlando R.C. Non erosive reflux disease: a pathophysiologic perspective. Curr Gastroenterol Rep 2008, 10:200-207.
19. Hirano I., Richter J.E. Practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007, 102:668-685. Practice Parameters Committee of the American College of Gastroenterology. ACG.
20. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003, 138:W1-W12.
21. Ronkainen J., Talley N.J., Aro P., et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 2007, 56:615-620.
22. Veerappan G.R., Perry J.L., Duncan T.J., et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol 2009, 7:420-426.
23. Prasad G.A., Talley N.J., Romero Y., et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007, 102:2627-2632.
24. Kerlin P., Jones D., Remedios M., et al. Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J Clin Gastroenterol 2007, 41:356-361.
25. Dranove J.E., Horn D.S., Davis M.A., et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr 2009, 154:96-100.
26. Shah A., Kagalwalla A.F., Gonsalves N., et al. Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol 2009, 104:716-721.
27. Remedios M., Campbell C., Jones D.M., et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006, 63:3-12.
28. Parfitt J.R., Gregor J.C., Suskin N.G., et al. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol 2006, 19:90-96.
29. Mueller S., Neureiter D., Aigner T., et al. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material. Histopathology 2008, 53:676-684.
30. Pentiuk S., Putnam P.E., Collins M.H., et al. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009, 48:152-160.
31. Spechler S.J., Genta R.M., Souza R.F. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007, 102:1301-1306.
32. Rothenberg M.E., Mishra A., Collins M.H., et al. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001, 108:891-894.
33. Kirsch R., Bokhary R., Marcon M.A., et al. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007, 44:20-26.
34. Ramakrishnan R., Chong H. Eosinophilic oesophagitis in adults. Histopathology 2008, 52:897-900.
35. Cortes J.R., Rivas M.D., Molina-Infante J., et al. Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma. J Allergy Clin Immunol 2009, 124:607-610.
36. Zhang X., Cheng E., Huo X., et al. In esophageal squamous epithelial cell lines from patients with eosinophilic esophagitis (EoE), omeprazole blocks the stimulated secretion of ootaxin-3: a potential anti-inflammatory effect of omeprazole in EoE that is independent of acid inhibition. Gastroenterology 2010, 138(Suppl 1):S-122.
37. Krarup A.L., Villadsen G.E., Mejlgaard E., et al. Acid hypersensitivity in patients with eosinophilic esophagitis. Scand J Gastroenterol 2010, 45:273-281.
38. Protheroe C., Woodruff S.A., de Petris G., et al. A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2009, 7:749-755.
39. Rothenberg M.E. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009, 137:1238-1249.
40. Gonsalves N., Policarpio-Nicolas M., Zhang Q., et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006, 64:313-319.